World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jul. 01, 2024

Rank Company Market Cap (USD) Country Sector Industry
661 Orthocell Limited $48.8 M Australia Australian Healthcare Australian Biotechnology
662 Aeglea BioTherapeutics, Inc. $48.6 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
663 Bonus BioGroup Ltd $48.4 M Israel Israeli Healthcare Israeli Biotechnology
664 BioVie Inc. $48.3 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
665 Sagittarius Life Science Corp $47.5 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
666 BioLineRx Ltd. $47.1 M Israel Israeli Healthcare Israeli Biotechnology
667 I-Tech AB $46.9 M Sweden Swedish Healthcare Swedish Biotechnology
668 Tissue Regenix Group plc $46.7 M

(Jan. 1, 2024)

United Kingdom UK Healthcare UK Biotechnology
669 Cue Biopharma, Inc. $46.7 M United States US Healthcare US Biotechnology
670 Arecor Therapeutics plc $45.5 M United Kingdom UK Healthcare UK Biotechnology
671 Cyclo Therapeutics, Inc. $45.2 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
672 Fortress Biotech, Inc. $44.5 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
673 Lantern Pharma Inc. $44.4 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
674 Sareum Holdings plc $44.3 M United Kingdom UK Healthcare UK Biotechnology
675 Eledon Pharmaceuticals, Inc. $44.3 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
676 Atara Biotherapeutics, Inc. $44.2 M United States US Healthcare US Biotechnology
677 Dyadic International, Inc. $44.2 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
678 Rain Therapeutics, Inc. $43.7 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
679 Gamida Cell Ltd. $42.3 M

(Jan. 1, 2024)

Israel Israeli Healthcare Israeli Biotechnology
680 Kezar Life Sciences, Inc. $42.2 M United States US Healthcare US Biotechnology
681 BerGenBio ASA $42.0 M Norway Norway Healthcare Norway Biotechnology
682 MedMira, Inc. $40.6 M Canada Canadian Healthcare Canadian Biotechnology
683 Carna Biosciences, Inc. $40.5 M Japan Japanese Healthcare Japanese Biotechnology
684 Ocuphire Pharma, Inc. $39.5 M United States US Healthcare US Biotechnology
685 BioXcel Therapeutics, Inc. $39.4 M United States US Healthcare US Biotechnology
686 Auris Medical Holding Ltd. $39.2 M

(June 1, 2022)

Bermuda Bermuda Healthcare Bermuda Biotechnology
687 Curis, Inc. $37.6 M United States US Healthcare US Biotechnology
688 Aligos Therapeutics, Inc. $37.0 M United States US Healthcare US Biotechnology
689 BeyondSpring Inc. $36.2 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
690 Reviva Pharmaceuticals Holdings, Inc. $35.8 M United States US Healthcare US Biotechnology

Top Biotechnology Companies in the World as of Jul. 01, 2024

661. Orthocell Limited

Company Profile: Orthocell Limited
Market Cap (USD): $48.8 M
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

662. Aeglea BioTherapeutics, Inc.

Company Profile: Aeglea BioTherapeutics, Inc.
Market Cap (USD): $48.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

663. Bonus BioGroup Ltd

Company Profile: Bonus BioGroup Ltd
Market Cap (USD): $48.4 M
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

664. BioVie Inc.

Company Profile: BioVie Inc.
Market Cap (USD): $48.3 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

665. Sagittarius Life Science Corp

Company Profile: Sagittarius Life Science Corp
Market Cap (USD): $47.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

666. BioLineRx Ltd.

Company Profile: BioLineRx Ltd.
Market Cap (USD): $47.1 M
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

667. I-Tech AB

Company Profile: I-Tech AB
Market Cap (USD): $46.9 M
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Biotechnology

668. Tissue Regenix Group plc

Company Profile: Tissue Regenix Group plc
Market Cap (USD): $46.7 M (Jan. 1, 2024)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

669. Cue Biopharma, Inc.

Company Profile: Cue Biopharma, Inc.
Market Cap (USD): $46.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

670. Arecor Therapeutics plc

Company Profile: Arecor Therapeutics plc
Market Cap (USD): $45.5 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

671. Cyclo Therapeutics, Inc.

Company Profile: Cyclo Therapeutics, Inc.
Market Cap (USD): $45.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

672. Fortress Biotech, Inc.

Company Profile: Fortress Biotech, Inc.
Market Cap (USD): $44.5 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

673. Lantern Pharma Inc.

Company Profile: Lantern Pharma Inc.
Market Cap (USD): $44.4 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

674. Sareum Holdings plc

Company Profile: Sareum Holdings plc
Market Cap (USD): $44.3 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

675. Eledon Pharmaceuticals, Inc.

Company Profile: Eledon Pharmaceuticals, Inc.
Market Cap (USD): $44.3 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

676. Atara Biotherapeutics, Inc.

Company Profile: Atara Biotherapeutics, Inc.
Market Cap (USD): $44.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

677. Dyadic International, Inc.

Company Profile: Dyadic International, Inc.
Market Cap (USD): $44.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

678. Rain Therapeutics, Inc.

Company Profile: Rain Therapeutics, Inc.
Market Cap (USD): $43.7 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

679. Gamida Cell Ltd.

Company Profile: Gamida Cell Ltd.
Market Cap (USD): $42.3 M (Jan. 1, 2024)
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

680. Kezar Life Sciences, Inc.

Company Profile: Kezar Life Sciences, Inc.
Market Cap (USD): $42.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

681. BerGenBio ASA

Company Profile: BerGenBio ASA
Market Cap (USD): $42.0 M
Country: Norway
Sector: Norway Healthcare
Industry: Norway Biotechnology

682. MedMira, Inc.

Company Profile: MedMira, Inc.
Market Cap (USD): $40.6 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

683. Carna Biosciences, Inc.

Company Profile: Carna Biosciences, Inc.
Market Cap (USD): $40.5 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

684. Ocuphire Pharma, Inc.

Company Profile: Ocuphire Pharma, Inc.
Market Cap (USD): $39.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

685. BioXcel Therapeutics, Inc.

Company Profile: BioXcel Therapeutics, Inc.
Market Cap (USD): $39.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

686. Auris Medical Holding Ltd.

Company Profile: Auris Medical Holding Ltd.
Market Cap (USD): $39.2 M (June 1, 2022)
Country: Bermuda
Sector: Bermuda Healthcare
Industry: Bermuda Biotechnology

687. Curis, Inc.

Company Profile: Curis, Inc.
Market Cap (USD): $37.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

688. Aligos Therapeutics, Inc.

Company Profile: Aligos Therapeutics, Inc.
Market Cap (USD): $37.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

689. BeyondSpring Inc.

Company Profile: BeyondSpring Inc.
Market Cap (USD): $36.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

690. Reviva Pharmaceuticals Holdings, Inc.

Company Profile: Reviva Pharmaceuticals Holdings, Inc.
Market Cap (USD): $35.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology